跳至主要内容
临床试验/NCT02921243
NCT02921243已完成不适用

Schizophrenia and the Gut Microbiome

University of Maryland, Baltimore1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
1
主要终点
16S rRNA gene amplicons from stool samples

研究概览

简要总结

In a sample of 20 inpatients with a DSM-IV-TR/DSM 5 diagnosis of schizophrenia or schizoaffective disorder, investigators propose to conduct a prospective, 2 week observational trial to collect gastrointestinal stool samples in order to characterize the microbiota in people with schizophrenia and examine its variability over time. Participants may elect to participate for an additional two weeks, during which they will receive the prebiotic, oligofructose-enriched inulin (FOS), in order to examine its effects on the relative preponderance of butyrate-producing bacteria in the gut microbiome. Investigators will use an inpatient sample in order to standardize meals, exercise and environmental mediators. This is considered a feasibility, pilot study in order to apply for future grant funding. Investigators will recruit patients from the Treatment Research Program inpatient unit, Maryland Psychiatric Research Center, University of Maryland School of Medicine.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • DSM-IV-TR /DSM 5 diagnosis of schizophrenia or schizoaffective disorder;
  • Age 18-64 years;
  • currently hospitalized for at least 7 days
  • currently treated with an antipsychotic, with no dose changes in last 14 days
  • ability to participate in the informed consent process, as determined by a score of 10 or greater on the Evaluation to Sign Consent

排除标准

  • Gastrointestinal disorders, including, but not limited to Crohn's Disease, Irritable Bowel Syndrome, Celiac Disease,
  • Organic brain disorder, including cerebrovascular accident; epilepsy; traumatic brain injury, Loss of consciousness (LOC) for more than 30 minutes
  • Mental retardation
  • Antibiotic or immune therapy within the last three months
  • Prebiotic or probiotic treatment within the last three months
  • Inability to understand English
  • Inability to cooperate with study procedures
  • Pregnant women
  • Prisoner status
  • For MRI ONLY Contraindication for MRI scanning (e.g. metal in body, pacemaker).

结局指标

主要结局

16S rRNA gene amplicons from stool samples

时间窗: 4 weeks

The 16S rRNA gene amplicon data will be used to examine the relative preponderance of butyrate-producing bacteria in the gut microbiota of people with schizophrenia.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Buchanan

Director, Maryland Psychiatric Research Cente

University of Maryland, Baltimore

研究点 (1)

Loading locations...

相似试验